B. Sheitman

S. Glickman, B. Sheitman, Julianne M. Cyr, 2018, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.

Implementing a smoking ban in an acute psychiatric admissions unit.

B. Sheitman, J. Kraus, A. Stephenson, 2005, Journal of psychosocial nursing and mental health services.

Are the negative symptoms of schizophrenia consistent with an autistic spectrum illness?

B. Sheitman, J. Bodfish, J. Kraus, 2004, Schizophrenia Research.

Olanzapine for Schizophrenia Refractory to Typical and Atypical Antipsychotics: An Open-Label, Prospective Trial

J. Lieberman, P. Czobor, J. Volavka, 2001, Journal of clinical psychopharmacology.

The development of a brief version of the Nurse's Observation Scale for inpatient Evaluation (NOSiE-30)

D. Penn, D. Combs, M. Hazelrigg, 2008 .

Relationship Between Use of Quality Measures and Improved Outcomes in Serious Mental Illness

M. Viswanathan, L. Lux, M. Ashok, 2015 .

Adverse effects of clomipramine.

James Robert Brašić, B. Sheitman, J. Barnett, 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

A pilot study of social cognition and interaction training (SCIT) for schizophrenia

D. Penn, B. Sheitman, E. Munt, 2005, Schizophrenia Research.

Behavioral Health Services in North Carolina's State Prison System

B. Sheitman, J. B. Williams, 2019, North Carolina Medical Journal.

A Model of Enhanced Primary Care for Patients with Severe Mental Illness

B. Sheitman, J. T. Wahrenberger, B. Steiner, 2018, North Carolina Medical Journal.

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.

J. Lieberman, R. Bilder, D. Robinson, 1999, Archives of general psychiatry.

The evaluation and treatment of first-episode psychosis.

J. Lieberman, B. Sheitman, R. Strous, 1997, Schizophrenia bulletin.

Biological predictors of antipsychotic treatment response

J. Lieberman, B. Sheitman, A. Koreen, 1996 .

Reducing Length of Acute Inpatient Hospitalization Using a Residential Step Down Model for Patients with Serious Mental Illness

B. Sheitman, A. Cook, Theodore R Zarzar, 2018, Community Mental Health Journal.

Characteristics of violent behavior in a large state psychiatric hospital.

B. Sheitman, J. Kraus, 2004, Psychiatric services.

Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization

J. Lieberman, G. Duncan, B. Sheitman, 1999, Molecular Psychiatry.

Premorbid functioning in schizophrenia: relation to baseline symptoms, treatment response, and medication side effects.

J. Lieberman, D. Robinson, B. Sheitman, 2004, Schizophrenia bulletin.

Suggestive association between the C825T polymorphism of the G-protein β3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia

J. Lieberman, P. Czobor, J. McEvoy, 2005, European Neuropsychopharmacology.

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.

J. Lieberman, P. Czobor, J. McEvoy, 2003, The American journal of psychiatry.

Managing Treatment Resistant Violent Adolescents: A Step Forward by Substituting Seclusion for Mechanical Restraint?

B. Sheitman, J. Kraus, Thomas C. Larson, 2008, Administration and Policy in Mental Health and Mental Health Services Research.

A Pilot Study of Risperidone, Olanzapine, and Haloperidol in Psychotic Youth: A Double-Blind, Randomized, 8-Week Trial

J. Lieberman, R. Hamer, B. Sheitman, 2004, Neuropsychopharmacology.

The Effects of an Enhanced Primary Care Model for Patients with Serious Mental Illness on Emergency Department Utilization

B. Sheitman, B. Steiner, Connor Belson, 2020, Community Mental Health Journal.

Future Research Needs for First- and Second-Generation Antipsychotics for Children and Young Adults

Alan R. Ellis, M. Viswanathan, R. Wines, 2012 .

Effect of Enhanced Primary Care for People with Serious Mental Illness on Service Use and Screening

B. Sheitman, M. Domino, Lexie R. Grove, 2021, Journal of General Internal Medicine.

The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia

J. Lieberman, W. Honer, P. Czobor, 2005, Neuroscience Letters.

Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorder.

J. Lieberman, P. Czobor, J. McEvoy, 2005, Journal of psychiatric research.

An integrated view of pathophysiological models of schizophrenia

G. Duncan, J. Lieberman, B. Sheitman, 1999, Brain Research Reviews.

Age of onset in schizophrenia

J. Lieberman, R. Bilder, B. Sheitman, 1995, Schizophrenia Research.

Clozapine reduces violent behavior in heterogeneous diagnostic groups.

B. Sheitman, J. Kraus, 2005, The Journal of neuropsychiatry and clinical neurosciences.

Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients.

J. Lieberman, J. Kane, B. Sheitman, 1995, The American journal of psychiatry.

Psychobiologic Correlates of Treatment Response in Schizophrenia

J. Lieberman, B. Sheitman, M. Chakos, 1996, Neuropsychopharmacology.

The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study.

Abraham Weizman, B. Sheitman, B. Spivak, 2003, The Journal of clinical psychiatry.

Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.

J. Lieberman, D. Bradford, B. Sheitman, 2001, The American journal of psychiatry.

Clozapine as a first treatment for schizophrenia.

J. Lieberman, D. Robinson, J. Kane, 2003, The American journal of psychiatry.

The natural history and pathophysiology of treatment resistant schizophrenia.

J. Lieberman, B. Sheitman, 1998, Journal of psychiatric research.

Tardive dyskinesia induced by risperidone?

J. Lieberman, J. Kane, B. Sheitman, 1996, The American journal of psychiatry.

Ziprasidone alternative for olanzapine-induced hyperglycemia.

J. Lieberman, B. Sheitman, L. Jarskog, 2002, The American journal of psychiatry.

Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder

J. Lieberman, P. Szeszko, G. Gerig, 2005, Psychiatry Research: Neuroimaging.

Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol.

J. Lieberman, P. Czobor, T. Cooper, 2004, The Journal of clinical psychiatry.

Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia.

J. Lieberman, R. Bilder, B. Sheitman, 1996, The Journal of clinical psychiatry.

A+KIDS, a web-based antipsychotic registry for North Carolina youths: an alternative to prior authorization.

B. Sheitman, J. Farley, S. Wegner, 2013, Psychiatric services.

Potential Lower Efficacy of Molindone Among First-Generation Antipsychotics

J. McClellan, L. Ritz, S. Hlastala, 2009 .

Use of Antipsychotic Medications in Pediatric and Young Adult Populations: Future Research Needs

Alan R. Ellis, R. Wines, T. Carey, 2015, Journal of psychiatric practice.

Psychiatric and criminal histories of persons referred for pretrial evaluations: Description and policy implications

M. Hazelrigg, B. Sheitman, A. L. Barrick, 2011 .

Atypical Antipsychotic Drugs in Treatment-Refractory Schizophrenia

J. Lieberman, D. Bradford, B. Sheitman, 1998 .

Tables of FDA-Approved Indications for First- and Second-Generation Antipsychotics

Alan R. Ellis, M. Viswanathan, R. Wines, 2012 .

Antipsychotic-Induced Weight Gain and Therapeutic Response: A Differential Association

J. Lieberman, P. Czobor, J. McEvoy, 2002, Journal of clinical psychopharmacology.

Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective Disorder

Jeffrey A. Lieberman, Brian Sheitman, Leslie Citrome, 2002 .

A Naturalistic Comparison of the Long-Term Metabolic Adverse Effects of Clozapine Versus Other Antipsychotics for Patients With Psychotic Illnesses

J. Gilmore, R. Hamer, D. Perkins, 2014, Journal of clinical psychopharmacology.

Management Strategies To Reduce Psychiatric Readmissions

M. Viswanathan, L. Lux, M. Ashok, 2015 .

Seasonal Admission Patterns in First Episode Psychosis, Chronic Schizophrenia, and Nonschizophrenic Psychoses

J. Lieberman, D. Robinson, B. Sheitman, 2001, The Journal of nervous and mental disease.

Adjunctive transdermal nicotine reduced behavioral agitation in severe dementia.

B. Sheitman, H. Carmel, 2007, The American journal of geriatric psychiatry.

Clozapine Reduces Self-Injurious Behavior in a State Prison Population

B. Sheitman, J. B. Williams, V. P. Wilson, 2019, The Journal of the American Academy of Psychiatry and the Law.

Dyskinesias Differentiate Autistic Disorder From Catatonia

James Robert Brašić, B. Sheitman, J. Barnett, 2000, CNS Spectrums.

Examining the Relationship Between Adjunctive Psychotherapy Use and Antipsychotic Persistence and Hospitalization

B. Sheitman, M. Maciejewski, J. Farley, 2014, Administration and Policy in Mental Health and Mental Health Services Research.

IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illness

J. Lieberman, J. Volavka, R. Goldman, 2000, Schizophrenia Research.

Secretin in a patient with treatment-resistant schizophrenia and prominent autistic features

Jeffrey A. Lieberman, L. Fredrik Jarskog, J. Lieberman, 2004, Schizophrenia Research.

COMT158 polymorphism and hostility

Brian Sheitman, Jeffrey A Lieberman, Leslie Citrome, 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Neurosyphilis in newly admitted psychiatric patients: three case reports.

Scott Mann, B. Sheitman, J. Kraus, 2004, The Journal of clinical psychiatry.

Search Strategy and Yields

Linda J Lux, Meera Viswanathan, Bradley N Gaynes, 2015 .

Olanzapine versus risperidone in newly admitted acutely ill psychotic patients.

J. Lieberman, B. Sheitman, J. Kraus, 2005, The Journal of clinical psychiatry.

Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation

J. Lieberman, P. Czobor, J. Volavka, 2005, Schizophrenia Research.

Secretin for refractory schizophrenia

Jeffrey A. Lieberman, Miranda Chakos, J. Lieberman, 2004, Schizophrenia Research.

Strategies To De-escalate Aggressive Behavior in Psychiatric Patients

K. Lohr, M. Viswanathan, L. Lux, 2016 .

Effect of Clozapine on Time Assigned to Restrictive Housing in a State Prison Population

D. Rosen, B. Sheitman, J. P. Mayo, 2021, The Journal of the American Academy of Psychiatry and the Law.